Changes in Bcl-2 and p53 expression in recurrent B-cell lymphomas

Journal of Pathology

Volumn 180, Issue 3, 1996, Pages 249-253

  Ilyas, M ^a   Kendall, M ^b   Jalal, H ^b   Linton, C ^b   Rooney, N ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

^c ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Clonal evolution; Lymphoma; p53; PCR

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER RECURRENCE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOMA, B-CELL; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECURRENCE; TUMOR STEM CELLS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029806983     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199611)180:3<249::AID-PATH672>3.0.CO;2-8     Document Type: Article

References (33)

1. Foulds L. The natural history of cancer. J Chronic Dis 1958; 8: 2-37.
2. Farber E. Cancer development and its natural history. A cancer prevention perspective. Cancer 1988; 62(8 Suppl): 1676-1679.
3. Weinberg RA. Oncogenes, antioncugenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989; 49: 3713-3721.
4. Weinberg RA. The integration of molecular genetics into cancer management. Cancer 1992; 70(6 Suppl): 1653-1658.
5. Knudson AG. Antioncogenes and human cancer. Proc Natl Acad Sci USA 1993; 90: 10914-10921.
6. Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
7. Hill MJ, Morson BC, Bussey HJ. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet 1978; 1: 245-247.
8. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-767.
9. Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA 1982; 79: 7824-7827.
10. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori, Lancet 1993; 342: 571-574.
11. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342: 575-577.
12. Harris NL, Jaffe ES, Stein H, et al. A revised European - American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
13. Shibata D, Martin WJ, Arnheim N. Analysis of DNA sequences in 40-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res 1988; 48: 4564-4566.
14. Ilyas M, Jalal H, Linton C, Rooney N. The use of the polymerase chain reaction in the diagnosis of B cell lymphomas from formalin fixed paraffin embedded tissue. Histopathologr 1995; 26: 333-338.
15. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol 1992; 45: 770-775.
16. Korsmeyer SJ. Bcl-2: a repressor of lymphocyte death, Immunol Today 1992; 13: 285-288.
17. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-886.
18. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-336.
19. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440-1443.
20. Tsujimoto Y, Gorham J, Crossman J, Jaffe E, Croce C. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Nature 1985; 229: 1390-1393.
21. Ashton-Key M, Biddolph SC, Stein H, Gatter KC, Mason DY. Heterogeneity of bcl-2 expression in MALT lymphoma. Histopathology 1995; 26: 75 78.
22. Steward CG, Goulden NJ, Katz F, et al. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 1994; 83; 1355-1362.
23. Pezzella F, Tse AG, Cordell JL, Pulford KA, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 1990; 137: 225-232.
24. Lane DP. p53, guardian of the genome. Nature 1992; 358: 15-16,
25. Donehower LA, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993; 1155: 181-205.
26. Villuendas R, Piris MA, Orradre JL, et al. p53 protein expression in lymphomas and reactive lymphoid tissue. J Pathol 1992; 166: 235-241.
27. Lo-Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289-2295.
28. Sander CA, Yano T, Clark HM. et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1994; 82: 1994-2004.
29. Piris MA, Pezella F, Martinez-Montero JC, et al. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br J Cancer 1994; 69: 337-341.
30. Cesarman E, Inghirami G, Chadburn A, Knowles DM. High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 1993; 143: 845-856.
31. Greenwald BD, Harpaz N, Yin J, et al. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992; 52: 741-745.
32. Kern SE, Redston M, Seymour AB, et al. Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994; 107: 420-428.
33. Bell SM, Kelly SA, Hoyle JA. et al. C-ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 1991; 64: 174-178.